Literature DB >> 9428678

Specificity and direction of depolymerization of beta-poly(L-malate) catalysed by polymalatase from Physarum polycephalum--fluorescence labeling at the carboxy-terminus of beta-poly(L-malate).

B Gasslmaier1, E Holler.   

Abstract

Beta-poly(L-malate), a major constituent of nuclei in plasmodia of Physarum polycephalum, is enzymatically degraded to L-malate after secretion into the culture medium. This depolymerization is specifically catalysed by an endogenous polymalatase. The mode of action and the specificity criteria have been investigated by employing various chemical derivatives of beta-poly(L-malate), including substitution at the hydroxy-terminus and carboxy-terminus of the polymer, esterification of the pending alpha-carboxylate, and beta-poly(DL-malate). The results of the investigation were summarized in a specificity model that involved recognition of the hydroxy-terminus and of the alpha-carboxylate as substituents of the asymmetric carbon in the malic acid unit. Depolymerization proceeded from the hydroxy-terminus towards the carboxy-terminus, thereby degrading the polymer to L-malate. When the terminal beta-carboxylate had been amidated with the fluorescent N-(1-naphthyl)ethylenediamine, degradation was normal but was arrested at the level of the terminal beta-carboxy-substituted dimer. It should be possible to employ polymalatase as a tool for the detection of branching and other modifications of beta-poly(L-malate).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428678     DOI: 10.1111/j.1432-1033.1997.0308a.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Calcium and malate are sporulation-promoting factors of Physarum polycephalum.

Authors:  S Renzel; S Esselborn; H W Sauer; A Hildebrandt
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

2.  Nanoconjugate Platforms Development Based in Poly(β,L-Malic Acid) Methyl Esters for Tumor Drug Delivery.

Authors:  José Portilla-Arias; Rameshwar Patil; Jinwei Hu; Hui Ding; Keith L Black; Montserrat García-Alvarez; Sebastián Muñoz-Guerra; Julia Y Ljubimova; Eggehard Holler
Journal:  J Nanotechnol       Date:  2010

Review 3.  Covalent nano delivery systems for selective imaging and treatment of brain tumors.

Authors:  Julia Y Ljubimova; Tao Sun; Leila Mashouf; Alexander V Ljubimov; Liron L Israel; Vladimir A Ljubimov; Vida Falahatian; Eggehard Holler
Journal:  Adv Drug Deliv Rev       Date:  2017-06-10       Impact factor: 15.470

4.  Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis.

Authors:  Manabu Fujita; Natalya M Khazenzon; Alexander V Ljubimov; Bong-Seop Lee; Ismo Virtanen; Eggehard Holler; Keith L Black; Julia Y Ljubimova
Journal:  Angiogenesis       Date:  2006-11-16       Impact factor: 9.596

5.  Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.

Authors:  Satoshi Inoue; Hui Ding; Jose Portilla-Arias; Jinwei Hu; Bindu Konda; Manabu Fujita; Andres Espinoza; Sonal Suhane; Marisa Riley; Marcus Gates; Rameshwar Patil; Manuel L Penichet; Alexander V Ljubimov; Keith L Black; Eggehard Holler; Julia Y Ljubimova
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

6.  Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).

Authors:  Manabu Fujita; Bong-Seop Lee; Natalya M Khazenzon; Manuel L Penichet; Kolja A Wawrowsky; Rameshwar Patil; Hui Ding; Eggehard Holler; Keith L Black; Julia Y Ljubimova
Journal:  J Control Release       Date:  2007-06-05       Impact factor: 9.776

7.  Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer.

Authors:  Satoshi Inoue; Rameshwar Patil; Jose Portilla-Arias; Hui Ding; Bindu Konda; Andres Espinoza; Dmitriy Mongayt; Janet L Markman; Adam Elramsisy; H Westley Phillips; Keith L Black; Eggehard Holler; Julia Y Ljubimova
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

Review 8.  Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?

Authors:  Babak Kateb; Katherine Chiu; Keith L Black; Vicky Yamamoto; Bhavraj Khalsa; Julia Y Ljubimova; Hui Ding; Rameshwar Patil; Jose Antonio Portilla-Arias; Mike Modo; David F Moore; Keyvan Farahani; Michael S Okun; Neal Prakash; Josh Neman; Daniel Ahdoot; Warren Grundfest; Shouleh Nikzad; John D Heiss
Journal:  Neuroimage       Date:  2010-02-10       Impact factor: 7.400

Review 9.  Biosynthetic Polymalic Acid as a Delivery Nanoplatform for Translational Cancer Medicine.

Authors:  Jianguo Zhang; Deyu Chen; Guoxin Liang; Wenrong Xu; Zhimin Tao
Journal:  Trends Biochem Sci       Date:  2020-10-22       Impact factor: 13.807

Review 10.  Polymalic acid for translational nanomedicine.

Authors:  Xing Huang; Liusheng Xu; Hui Qian; Xinghuan Wang; Zhimin Tao
Journal:  J Nanobiotechnology       Date:  2022-06-21       Impact factor: 9.429

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.